scholarly journals microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin

2013 ◽  
Vol 6 (3) ◽  
pp. 789-794 ◽  
Author(s):  
ZHONGXIAN WANG ◽  
ZHOU TING ◽  
YA LI ◽  
GANG CHEN ◽  
YUNPING LU ◽  
...  
2020 ◽  
Vol 19 (2) ◽  
pp. 206-210
Author(s):  
Feng Chen ◽  
Bei Zhang

Lupeol exhibits multiple pharmacological activities including, anticancerous, anti-inflammatory, and antioxidant. The aim of this study was to explore the anticancerous activity of lupeol on ovarian cancer cells and examine its mechanism of action. To this end, increasing concentrations of lupeol on cell viability, cell cycle, and apoptosis in Caov-3 cells were evaluated. Lupeol inhibited cell viability, induced G1 phase arrest in cell cycle, increased cell apoptosis, and inhibited the ratio of phospho-Akt/protein kinase B and phospho-mammalian target of rapamycin/mammalian target of rapamycin. In conclusion, these data suggest that lupeol may play a therapeutic role in ovarian cancer.


2014 ◽  
Vol 25 (7) ◽  
pp. 799-809 ◽  
Author(s):  
Huijuan Wu ◽  
Zhenghua Xiao ◽  
Hua Zhang ◽  
Ke Wang ◽  
Wenxin Liu ◽  
...  

Neoplasma ◽  
2015 ◽  
Vol 62 (03) ◽  
pp. 432-438 ◽  
Author(s):  
F. WANG ◽  
J. ZHOU ◽  
X. XIE ◽  
J. HU ◽  
L. CHEN ◽  
...  

2011 ◽  
Vol 47 (10) ◽  
pp. 1585-1594 ◽  
Author(s):  
Huimei Yu ◽  
Jing Su ◽  
Ye Xu ◽  
Jinsong Kang ◽  
Hongyan Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document